Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
| ▸ | GSK3B | P49841 | 2/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11852009 | 0.80 | CES2 (0.31) | CES2CES1GSK3BPTPN1 | |
| SCHEMBL4858511 | 0.74 | — | — | |
| SCHEMBL6280420 | 0.74 | — | — | |
| SCHEMBL4850674 | 0.73 | THRB (0.39) | CES1 | |
| SCHEMBL4853503 | 0.73 | — | — | |
| SCHEMBL4854360 | 0.73 | — | — | |
| Fluoride SCHEMBL8995108 | 0.73 | GSK3B (0.31) | GSK3B | |
| SCHEMBL404184 | 0.72 | LMNA (0.30) | — | |
| SCHEMBL20377897 | 0.71 | CA2 (0.30) | CES2CA2 | |
| SCHEMBL4848395 | 0.71 | THRB (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7414148-B2 | Process for producing alkoxycarbonylfluoroalkanesulfonates | CENTRAL GLASS COMPANY LIMITED (JP) | 2008-08-19 | — | — | US | disclosed |
| US-20080108846-A1 | PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES | CENTRAL GLASS COMPANY, LIMITED (JP) | 2008-05-08 | — | — | US | disclosed |
| US-4831085-A | CONTAINING (2-OR 3-) BROMOPERFLUOROPROPYL PERFLUOROVINYL ETHER | NIPPON MEKTRON, LIMITED (JP) | 1989-05-16 | — | — | US | disclosed |
| EP-0287004-A2 | Method for the production of esters of trifluoroacrylic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108846-A1 | PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES | ARSA, PFAS, MPST | CES2 664/4885CES1 815/4885GSK3B 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.